Trials / Conditions / Shwachman-Diamond Syndrome

Shwachman-Diamond Syndrome

13 registered clinical trials studyying Shwachman-Diamond Syndrome — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform NCT06999954	Shwachman-Diamond Syndrome Alliance Inc	—
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Completed	Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marro NCT04965597	Fred Hutchinson Cancer Center	Phase 2
Terminated	Diabetes/ Endocrine Surveillance in SDS NCT04275479	Washington University School of Medicine	—
Terminated	Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Pa NCT03333486	Roswell Park Cancer Institute	Phase 2
Recruiting	Shwachman Diamond Syndrome Registry and Study NCT06056908	Boston Children's Hospital	—
Terminated	Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies NCT02179359	Masonic Cancer Center, University of Minnesota	N/A
Completed	Bone Marrow Transplant With Abatacept for Non-Malignant Diseases NCT01917708	Emory University	Phase 1
Completed	Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem NCT01529827	Roswell Park Cancer Institute	Phase 2
Completed	Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment NCT00499070	University Hospital Freiburg	—
Completed	Stem Cell Transplant for Hemoglobinopathy NCT00176852	Masonic Cancer Center, University of Minnesota	Phase 2 / Phase 3
Recruiting	Cancer in Inherited Bone Marrow Failure Syndromes NCT00027274	National Cancer Institute (NCI)	—
Completed	Stem Cell Transplant for Bone Marrow Failure Syndromes NCT00176878	Masonic Cancer Center, University of Minnesota	Phase 2 / Phase 3